Conclusion: Treating chronic idiopathic urticaria with levocetirizine is a dominant strategy for society since it is more effective (in terms of pruritus-free days gained) and less costly than ...
Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.
Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report) on January 10 and set a price ...
Analyst Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report) and increased the price ...
The biotech had previously been testing the oral itch medication in individuals with advanced chronic kidney disease ... which is in a phase 2 trial for idiopathic pulmonary fibrosis and a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback